Zobrazeno 1 - 10
of 29
pro vyhledávání: ''
Autor:
Tetsuya Tatsumi, Eri Gouda, Nana Tanaka, Miyuki Kobara, Hiroyuki Yamada, Hiroaki Matsubara, Tetsuo Nakata, Hironori Hayashi, Hiroe Toba, Masaki Abe
Publikováno v:
Hypertension Research. 31:363-375
The roles of aldosterone in the progression of heart failure have not been fully elucidated. This study examined whether aldosterone nongenomically activates reactive oxygen species (ROS) production, causing myocyte apoptosis. Addition of aldosterone
Autor:
Gen Matsuzaki, Eisei Noiri, Kan Saito, Kazuhiko Koike, Ryozo Nagai, Kyoko Furuta, Nobukazu Ishizaka
Publikováno v:
Hypertension Research. 30:195-202
Due to recent discoveries of novel genes involved in iron metabolism, our understanding of the molecular mechanisms underlying iron metabolism has dramatically increased. We have previously shown that the administration of angiotensin II alters iron
Autor:
Toshihiko Kuroiwa, Denan Jin, Shinji Takai, Mizuo Miyazaki, Shin-Ichi Miyatake, Nao Inoue, Keiichi Furubayashi, Yoshinaga Kajimoto, Hidekazu Tanaka
Publikováno v:
Hypertension Research. 30:469-475
We investigated whether an angiotensin-converting enzyme (ACE) inhibitor could inhibit matrix metalloproteinase (MMP) activities in cerebral infarct lesions after middle cerebral artery occlusion (MCAO) in rats. After placebo or trandolapril (5 mg/kg
Publikováno v:
Hypertension Research. 30:1247-1254
Accumulating evidence suggests an important role of the calcineurin signaling pathway in mediating the development of cardiac hypertrophy. It has also been reported that angiotensin-converting enzyme inhibitors (ACEIs) regressed cardiac hypertrophy i
Autor:
Mamoru Fujita, Akira Nishiyama, Akira Miyatake, Shoji Kimura, Yukiko Nagai, Youichi Abe, Guang-Ping Sun, Naohisa Hosomi, Ryoko Baba, Yu-Yan Fan, Masakazu Kohno
Publikováno v:
Hypertension Research. 29:169-178
Recent studies have suggested that aldosterone plays a role in the pathogenesis of renal injury. In this study, we investigated whether local angiotensin II (Ang II) activity contributes to the progression of renal injury in aldosterone/salt-induced
Autor:
Hidetoshi Okazaki, Naoki Mochizuki, Seiji Takashima, Masafumi Kitakaze, Ken-ichiro Okada, Jiyoong Kim, Masakatsu Wakeno, Tetsuo Minamino, Masafumi Myoishi, Osamu Tsukamoto
Publikováno v:
Hypertension Research. 29:277-284
The prevalence of atrial fibrillation (AF) increases in patients with hypertension. Angiotensin II is involved in structural atrial remodeling, which contributes to the onset and maintenance of AF in paced animal models. We investigated the role of a
Autor:
Shinya Taniguchi, Haruki Sasaki, Nobuyuki Ura, Hideaki Yoshida, Masaya Hyakkoku, Jun Agata, Yasuyuki Shinshi, Kazuaki Shimamoto
Publikováno v:
Hypertension Research. 29:865-874
Angiotensin II receptor blockers (ARBs) are widely used for the treatment of hypertension. It is believed that treatment with an ARB increases the level of plasma angiotensin II (Ang II) because of a lack of negative feedback on renin activity. Howev
Autor:
Mizuo Miyazaki, Katsuhiro Yoshikawa, Mika Nakabayashi, Shinji Takai, Kanta Kishi, Yoshiki Mino, Denan Jin, Kazuyoshi Kirimura, Michiko Muramatsu
Publikováno v:
Hypertension Research. 28:457-464
Vascular smooth muscle cells in spontaneously hypertensive rats (SHR) express angiotensin II-forming chymase (rat vascular chymase [RVCH]), which may contribute to blood pressure regulation. In this study, we studied whether chymase-dependent angiote
Autor:
Tsuguru Hatta, Noriko Kuwahara, Tetsurou Kusaba, Kazuo Takeda, S. Tanda, Hiromichi Narumiya, Keiichi Tamagaki, Hisako Kameyama, Mitsuhiko Okigaki, Susumu Sasaki, Keiko Yamada
Publikováno v:
Hypertension Research. 28:439-445
We examined the relationship between structural changes of the aorta and pulse wave velocity (PWV), and the effects of antihypertensive treatments on PWV in N(omega)-nitro-L-arginine methyl ester (L-NAME)-treated rats. Twelve-week-old Wistar-Kyoto (W
Autor:
Yoshiki Mino, Katsuhiro Yoshikawa, Kazuyoshi Kirimura, Denan Jin, Mizuo Miyazaki, Shinji Takai, Michiko Muramatsu
Publikováno v:
Hypertension Research. 28:593-600
Although the lipophilicities of the various angiotensin II receptor blockers (ARBs) are very different, the relationship between lipophilicity and the protective effect against vascular remodeling is unclear. In this study, we compared the protective